ArticleThe Journal of clinical investigation2005

Human cardiac potassium channel DNA polymorphism modulates access to drug-binding site and causes drug resistance.

Benoit Drolet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.